CPC technology class · G16
G16B - Bioinformatics
Bioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology. 6,310 US utility patents granted 2015–2025, with the leading assignees and year-by-year grant trajectory.
- 6,310
- US patents granted
- #2/5
- in G16
- 11.2%
- G16 class share
- +67%
- 5-yr velocity
The verdict
According to USPTO PatentsView, Bioinformatics ranks #227 of 670 CPC technology areas - 6,310 US patents granted since 2015, with recorded grant volume up 67% over five years.
- #227
- of 670 CPC technology areas
- 6,310
- US patents granted, 2015–2025
- International Business…
- leading assignee (144)
- +67%
- grant velocity, last 5 yrs
How G16B's grant cadence moved
Between 2020–2024, G16B recorded 3,304 grants versus 1,983 in 2015–2019 (+67% equal-window velocity). Across complete years, output peaked in 2023 at 738 grants and bottomed in 2015 at 278 (+165% peak-over-trough). Lead assignee Illumina, Inc. holds 2.0% of the class ; the top three share 5.5%.
Leaderboard read
G16B concentration, lead at 2.0%
Illumina, Inc. leads this historical grant record at 2.0% of G16B - us corporation assignees hold 76% of class grants (2,840 of 3,726). Figures describe granted US utility patents in this CPC subclass, not current investment or legal strength.
- Leader's share
- 2.0%
- Top three share
- 5.5%
- Lead over #2
- 16
129 of 6,310 grants
of the class's recorded grants
more grants than Life Technologies Corporation
Where G16B sits inside G16
Among 5 subclasses in G16 (Information AND Communication Technology [ICT] Specially Adapted FOR Specific Application Fields), G16B ranks #2 and holds 11.2% of the parent class's 56,268 recorded grants. Sibling chips below are the other subclasses in the same parent class, not the nationwide volume/lead-share peers further down.
Rising assignees active in G16B
Company-wide grant multiples (2022–2024 vs 2019–2021) among assignees with ≥5 patents in this subclass. Growth is company-wide; class patent counts are subclass-specific.
- #1 Optum Services (Ireland) Limited 26x 3 → 77 company-wide · 11 in G16B
- #2 Neumora Therapeutics, Inc. 16x 0 → 16 company-wide · 6 in G16B
- #3 Catalog Technologies, Inc. 12x 1 → 12 company-wide · 9 in G16B
- #4 Peptilogics, Inc. 10x 1 → 10 company-wide · 9 in G16B
- #5 Billiontoone, Inc. 9.00x 0 → 9 company-wide · 8 in G16B
G16B grants by year, peak 2023 (738)
US utility-patent grants per year in G16B, 2015–2025 - recent five years are up 67% versus 2015–2019.
Who leads G16B?
The 12 most active assignees in Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology - wider bars mean more grants
- Illumina
Illumina, Inc.
129 patents
- Life
Life Technologies Corporation
113 patents
- Immatics Biotechnologi…
Immatics Biotechnologies GmbH
107 patents
- Guardant Health
Guardant Health, Inc.
101 patents
- The Board of Trustees…
The Board of Trustees of the Leland Stanford Junior University
87 patents
- Heartflow
Heartflow, Inc.
86 patents
- 23andme
23andMe, Inc.
77 patents
- The Chinese University…
The Chinese University of Hong Kong
74 patents
- Seven Bridges Genomics
Seven Bridges Genomics Inc.
60 patents
- ubiome
uBiome, Inc.
58 patents
- Natera
Natera, Inc.
56 patents
- The Broad Institute 44
The Broad Institute, Inc.
44 patents
What this shows International… is the most active filer in G16B, holding 144 of the 6,310 patents in this class. Concentration at the top signals how contestable this technology area is for new entrants.
View data table
| Rank | Company | Patents in G16B |
|---|---|---|
| #1 | Illumina, Inc. | 129 |
| #2 | Life Technologies Corporation | 113 |
| #3 | Immatics Biotechnologies GmbH | 107 |
| #4 | Guardant Health, Inc. | 101 |
| #5 | The Board of Trustees of the Leland Stanford Junior University | 87 |
| #6 | Heartflow, Inc. | 86 |
| #7 | 23andMe, Inc. | 77 |
| #8 | The Chinese University of Hong Kong | 74 |
| #9 | Seven Bridges Genomics Inc. | 60 |
| #10 | uBiome, Inc. | 58 |
| #11 | Natera, Inc. | 56 |
| #12 | The Broad Institute, Inc. | 44 |
| #13 | Sequenom, Inc. | 42 |
| #14 | Nant Holdings IP, LLC | 37 |
| #15 | 10x Genomics, Inc. | 37 |
| #16 | KPN Innovations LLC | 36 |
| #17 | Ancestry.com DNA, LLC | 36 |
| #18 | Grail, Inc. | 35 |
| #19 | Personalis, Inc. | 34 |
| #20 | Verinata Health, Inc. | 33 |
Footprint here vs. claim strategy
Each dot is a leading G16B assignee, placed by how many patents it holds in this class (horizontal) against its company-wide average claims per patent (vertical) - a read on whether the class is led by broad-but-shallow filers or focused deep-claim players.
Classes near G16B's 6,310-grant footprint
Nationwide nearest neighbors for G16B (#227 of 670 by volume ; lead share 2.3%) - not the G16 parent-class siblings above.
Nearest by grant volume
Questions about G16B
Which company holds the most patents in G16B?
Which G16B assignees grew fastest recently?
How does G16B compare inside parent class G16?
What to do with this data
G16B in context - here's where to go next.
- Illumina, Inc. leads G16B with 129 grants in this class. See full portfolio
- G16B ranks #227 of 670 by grant volume among all tracked CPC technology areas. See the ranking
- Inside parent class G16, the largest sibling subclass is G16H with 42,899 grants. Explore G16H
Figures reflect USPTO PatentsView grant data through 2026-05-15; pending applications not yet granted are not counted.
Methodology - G16B figures are USPTO PatentsView granted-utility totals for this subclass (6,310 grants in the tracked window).
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.